4
Changes in Ownership
PLIANT THERAPEUTICS, INC. Filed Acc 0001209191-23-042825
Chief Financial Officer sold 19,771 shares at $18.01 ($356,058)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cummings Keith Lamont Chief Financial Officer | 2023-07-17 | Sale 10b5-1 | −19,771 | $18.01 | $356,058 | 203,999 | D |
| Open-market sales · 19,771 sh · avg $18.01 · $356,058 | |||||||
Loading xslF345X05/doc4.xml…